Latest Nebulizer Stories
Kamada has completed a Phase II study with aerosolized alpha-1 antitrypsin, delivered via an optimized eFlow platform nebulizer from PARI Pharma, in cystic fibrosis.
Kamada (TASE: KMDA), a bio-pharmaceutical company (www.kamada.com) engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today that it has completed a Phase II Study with Aerosolized Alpha-1 Antitrypsin (AAT), delivered via an optimized eFlow platform nebulizer (PARI Pharma GmbH), in cystic fibrosis (CF).
By Annie Getsinger, Herald & Review, Decatur, Ill. Jul.
SILVER SPRING, Md., June 30 /PRNewswire-FirstCall/ -- United Therapeutics Corporation and its wholly-owned subsidiary, Lung Rx, Inc., announced today the submission of a New Drug Application (NDA) to the U.S.
The nightmare seems to continue for the victims of Hurricane Katrina like Gina Bouffanie and her daughter. Since leaving their FEMA trailer Bouffanieâ€™s daughter has suffered severe breathing problems.
By David Douglas NEW YORK (Reuters Health) - An i
Indoor allergens can contaminate asthmatic children's nebulizer equipment, with potentially serious consequences for sensitive individuals, according to Maryland-based researchers.
Battling a child's asthma attack could be as simple as sliding a plastic tube onto the end of an inhaler, but many health-care providers don't offer this option to parents, say University of Florida researchers, who are calling for change.
- Forsooth! indeed! originally a parenthetical phrase used in repeating the words of another with more or less contempt or disdain.